Jasper Therapeutics Inc (JSPR)
Healthcare
Biotechnology
0.63 $
+1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Jasper Therapeutics Inc (JSPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -77 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -2.0 | -18 | -34 | -46 | -52 | -63 | -77 | |
| 0.4 | 0.0 | 0.4 | 1.3 | 1.1 | 1.4 | 1.1 | |
| 0.0 | 1.2 | 1.0 | 4.1 | 5.2 | 6.6 | 6.7 | |
| 1.1 | 5.9 | 0.5 | -8.8 | – | – | – | |
| 1.4 | 1.3 | 1.6 | -0.6 | 5.1 | 0.2 | -4.9 | |
| 2.4 | 2.4 | 2.4 | 0.6 | 0.3 | 0.6 | 0.0 | |
| -2.4 | 0.2 | -2.4 | -0.6 | -0.3 | -0.5 | 0.0 | |
| – | – | 5.7 | 0.0 | -1.0 | 0.4 | 0.2 | |
| 1.5 | – | – | 0.1 | – | – | – | |
| 29 | 11 | 101 | 0.1 | 101 | 48 | 34 | |
| 27 | -7.0 | 65 | -46 | 49 | -15 | -43 | |
| -2.0 | -18 | -36 | -46 | -52 | -63 | -77 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.